Table 3.
In-hospital and 2-year clinical outcomes after acute myocardial infarction
Low HDL | Normal HDL | p-value | |
---|---|---|---|
In-hospital | |||
Death | 8 (1.72) | 3 (0.58) | 0.089 |
Cardiogenic shock | 10 (2.15) | 6 (1.16) | 0.218 |
Acute renal failure | 5 (1.08) | 2 (0.39) | 0.199 |
Major bleeding | 4 (0.86) | 6 (1.16) | 0.644 |
During follow-up period | |||
MACE | 34 (7.44) | 18 (3.49) | 0.006 |
Cardiac death | 17 (3.72) | 5 (0.97) | 0.004 |
Non-fatal MI | 8 (1.75) | 8 (1.55) | 0.806 |
TVR | 16 (3.50) | 5 (0.97) | 0.007 |
Non-TVR | 11 (2.41) | 12 (2.33) | 0.934 |
Stent thrombosis, definite | 3 (0.65) | 1 (0.19) | 0.266 |
Data are presented as numbers (%) for categorical variables. MACE major adverse cardiac event, MI myocardial infarction, TVR target vessel revascularization